Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity-Reference-Cited by-同舟云学术

Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity

Published:2013-12 Issue:1-2 Volume:194 Page:289-299
ISSN:0166-0934
Container-title:Journal of Virological Methods
language:en
Short-container-title:Journal of Virological Methods

Author:

Phalaphol Aninthita,Thueng-in Kanyarat,Thanongsaksrikul Jeeraphong,Poungpair Ornnuthchar,Bangphoomi Kunan,Sookrung Nitat,Srimanote Potjanee,Chaicumpa Wanpen

Funder

the Thailand Research Fund

the National Research University

Publisher

Elsevier BV

Subject

Virology

Reference36 articles.

1. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels;Carreño;J. Infect. Dis.,2006

2. Humanized-single domain antibodies (VH/VHH) that bound specifically to Naja kaouthia phospholipase A2 and neutralized the enzymatic activity;Chavanayarn;Toxins,2012

3. Mechanism of action of interferon and ribavirin in treatment of hepatitis C;Feld;Nature,2005

4. Electrostatic analysis of the hepatitis C virus NS3 helicase reveals both active and allosteric site locations;Frick;Nucleic Acids Res.,2004

5. The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target;Frick;Curr. Issues Mol. Biol.,2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons;World Journal of Microbiology and Biotechnology;2024-05-21

2. Single domain antibodies from camelids in the treatment of microbial infections;Frontiers in Immunology;2024-05-17

3. Single-domain antibodies applied as antiviral immunotherapeutics;Journal of Virological Methods;2023-10

4. Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update;International Journal of Biological Macromolecules;2023-02

5. Classes and Applications of Cell-Penetrating Peptides;CPP, Cell-Penetrating Peptides;2023